![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 50, 39073-39080, December 15, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Medicine, Division of Hematology and
Molecular Oncology Group, Royal Victoria Hospital, McGill University,
Montreal, Quebec H3A 1A1, Canada
The protein-tyrosine phosphatase SHP-2 modulates
signaling events through receptor tyrosine kinases and cytokine
receptors including the receptor for prolactin (PRLR). Here we
investigated mechanisms of SHP-2 recruitment within the PRLR signaling
complex. Using SHP-2 and PRLR immunoprecipitation studies in 293 cells and in the mouse mammary epithelial cell line HC11, we found that SHP-2
co-immunoprecipitates with the PRLR and that the C-terminal tyrosine of
the PRLR plays a regulatory role in both the tyrosine phosphorylation
and the recruitment of SHP-2. Our results further indicate that SHP-2
association to the PRLR occurs via the C-terminal SH2 domain of the
phosphatase. In addition, we determined that the newly identified
adaptor protein Gab2, but not Gab1, is specifically tyrosine
phosphorylated and is able to recruit SHP-2 and phosphatidyinositol 3-kinase in response to PRLR activation. Together, these studies suggest the presence of dual recruitment sites for SHP-2; the first is
to the C-terminal tyrosine of the PRLR and the second is to the adaptor
protein Gab2.
Recruitment of the Protein-tyrosine Phosphatase SHP-2 to the
C-terminal Tyrosine of the Prolactin Receptor and to the Adaptor
Protein Gab2*
and
*
This work was supported by Medical Research Council of
Canada Grant MOP-13681 (to Su. A.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of the Fonds de la Recherche en Santé du
Québec Studentship Award.
§
Fonds de la Recherche en Santé du Québec
scholar. To whom correspondence should be addressed: Royal Victoria
Hospital, Molecular Oncology Group, H5-81, 687 Pine Ave. West,
Montreal, PQ H3A 1A1, Canada. Tel.: 514-842-1231, Ext. 4863; Fax:
514-843-1478: E-mail: Suhad.Ali@muhc.mcgill.ca.
This article has been cited by other articles:
![]() |
S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta} Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Qazi, C.-H. Tsai-Morris, and M. L. Dufau Ligand-Independent Homo- and Heterodimerization of Human Prolactin Receptor Variants: Inhibitory Action of the Short Forms by Heterodimerization Mol. Endocrinol., August 1, 2006; 20(8): 1912 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ali, Z. Nouhi, N. Chughtai, and S. Ali SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor J. Biol. Chem., December 26, 2003; 278(52): 52021 - 52031. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferjoux, F. Lopez, J.-P. Esteve, A. Ferrand, E. Vivier, F. Vely, N. Saint-Laurent, L. Pradayrol, L. Buscail, and C. Susini Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell Proliferation Mol. Biol. Cell, September 1, 2003; 14(9): 3911 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seiffert, J. M. Custodio, I. Wolf, M. Harkey, Y. Liu, J. N. Blattman, P. D. Greenberg, and L. R. Rohrschneider Gab3-Deficient Mice Exhibit Normal Development and Hematopoiesis and Are Immunocompetent Mol. Cell. Biol., April 1, 2003; 23(7): 2415 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chughtai, S. Schimchowitsch, J.-J. Lebrun, and S. Ali Prolactin Induces SHP-2 Association with Stat5, Nuclear Translocation, and Binding to the beta -Casein Gene Promoter in Mammary Cells J. Biol. Chem., August 16, 2002; 277(34): 31107 - 31114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shillingford, K. Miyoshi, G. W. Robinson, S. L. Grimm, J. M. Rosen, H. Neubauer, K. Pfeffer, and L. Hennighausen Jak2 Is an Essential Tyrosine Kinase Involved in Pregnancy-Mediated Development of Mammary Secretory Epithelium Mol. Endocrinol., March 1, 2002; 16(3): 563 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |